Search research articles
Contact Us
Filters
Showing results (491-500 of 692) with videos related to
Page
of 70
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 18, 2008
Expression of prostate-specific membrane antigen in renal cortical tumors
Hikmat A Al-Ahmadie, Semra Olgac, Polly D Gregor, et al.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of Principle
Govindaswami Ragupathi, Susan F Slovin, Sucharita Adluri, et al.
Neuroimage
|
April 17, 2007
Hippocampal shape analysis in Alzheimer's disease: a population-based study
A I Scher, Y Xu, E S C Korf, et al.
Journal of Pain and Symptom Management
|
December 7, 2010
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)
Thomas M Atkinson, Barry D Rosenfeld, Laura Sit, et al.
European Urology Oncology
|
May 22, 2021
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy
Stephen Harland, John Staffurth, Arturo Molina, et al.
Urologic Oncology
|
October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
Matthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
Cancer Cell
|
September 3, 2002
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
David B Agus, Robert W Akita, William D Fox, et al.
International Journal of Cancer
|
January 26, 2012
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease
Vanessa C Thompson, Tanya K Day, Tina Bianco-Miotto, et al.
Cancer Research
|
October 19, 2007
Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha
Grant Buchanan, Carmela Ricciardelli, Jonathan M Harris, et al.
Page
of 70
Search research articles
Search
Showing results (491-500 of 692) with videos related to
Sort By:
Page
of 70
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 18, 2008
Expression of prostate-specific membrane antigen in renal cortical tumors
Hikmat A Al-Ahmadie, Semra Olgac, Polly D Gregor, et al.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of Principle
Govindaswami Ragupathi, Susan F Slovin, Sucharita Adluri, et al.
Neuroimage
|
April 17, 2007
Hippocampal shape analysis in Alzheimer's disease: a population-based study
A I Scher, Y Xu, E S C Korf, et al.
Journal of Pain and Symptom Management
|
December 7, 2010
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)
Thomas M Atkinson, Barry D Rosenfeld, Laura Sit, et al.
European Urology Oncology
|
May 22, 2021
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy
Stephen Harland, John Staffurth, Arturo Molina, et al.
Urologic Oncology
|
October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
Matthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
Cancer Cell
|
September 3, 2002
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
David B Agus, Robert W Akita, William D Fox, et al.
International Journal of Cancer
|
January 26, 2012
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease
Vanessa C Thompson, Tanya K Day, Tina Bianco-Miotto, et al.
Cancer Research
|
October 19, 2007
Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha
Grant Buchanan, Carmela Ricciardelli, Jonathan M Harris, et al.
Page
of 70